Startseite Thalassaemic Osteopathy: a cross-sectional preliminary study from Sri Lanka
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Thalassaemic Osteopathy: a cross-sectional preliminary study from Sri Lanka

  • Ruwangi Dissanayake EMAIL logo , Shamya de Silva , Sarath Lekamwasam , Gayan Abeysekara und Vajira H. W. Dissanayake
Veröffentlicht/Copyright: 16. Oktober 2013

Abstract

Introduction: The objectives of this study were to demonstrate the presence of low bone mineral density (BMD) and to examine the association of known risk factors for low BMD in patients with beta thalassaemia major in Sri Lanka.

Method: Thirty-eight patients were studied. Their examination and laboratory investigation findings were recorded (haematology, biochemistry, hormonal profile, COL1A1 rs1800012G>T genotype, dual energy X-ray absorptiometry (DXA) scanning).

Results: Mean age was 10.95 years (range 5–21.4). 20 (52.6%) were male. BMD was low (z score ≤–2.0) in 12 (31.5%). Regression analysis of BMD on known risk factors (age, sex, pubertal stage, ferritin level, average pre-transfusion haemoglobin, serum calcium level and COL1A1 rs1800012G>T genotype) controlling for confounding factors on each comparison, showed that only age was significantly associated with low BMD (p=0.005).

Conclusions: Approximately one-third of patients had a low BMD. Only age was significantly associated with a low BMD.


Corresponding author: Dr. Ruwangi Dissanayake, Consultant Paediatrician, University Paediatrics Unit, Lady Ridgeway Hospital for Children, Colombo, Sri Lanka, Phone: +94773515233, E-mail:

References

1. Cooley TB, Lee P. A series of cases of splenomegaly in children with anaemia and peculiar bone changes. Trans Am Pediatr Soc 1925;37:29–30.Suche in Google Scholar

2. Modell B, Letsky EA, Flynn DM, Peto R, Weatherall DJ. Survival and desferrioxamine in thalassaemia major. Br Med J (Clin Res Ed) 1982;284:1081–4.Suche in Google Scholar

3. Chatterjee R, Bajoria R. Osteopenia-osteoporosis syndrome in patients with thalassemia: understanding of type of bone disease and response to treatment. Hemoglobin 2009;33 (suppl 1):136–8.Suche in Google Scholar

4. Shaw NJ. Management of osteoporosis in children. Eur J Endocrinol 2008;159 (suppl 1):33–9.Suche in Google Scholar

5. Voskaridou E, Terpos E. Pathogenesis and management of osteoporosis in thalassemia. Pediatr Endocrinol Rev 2008;6(suppl 1):86–93.Suche in Google Scholar

6. Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, et al. Thalassemia Clinical Research Network. Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res 2009;24:543–57.Suche in Google Scholar

7. Arisal O, Deviren A, Fenerci EY, Hacihanefioglu S, Ulutin T, et al. Polymorphism analysis in the COL1A1 gene of patients with thalassaemia major and intermedia. Haematologia (Budap) 2002;32:475–82.Suche in Google Scholar

8. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, et al. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 1996;14:203–5.Suche in Google Scholar

9. Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord 2003;3:4.Suche in Google Scholar

10. Karimi M, Ghiam AF, Hashemi A, Alinejad S, Soweid M, et al. Bone mineral density in beta-thalassemia major and intermedia. Indian Pediatr 2007;44:29–32.Suche in Google Scholar

11. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, et al. B. High prevalence of low bone mass in thalassaemia major. Br J Haematol 1998;103:911–5.Suche in Google Scholar

12. Aslan I, Canatan D, Balta N, Kacar G, Dorak C, et al. Bone mineral density in thalassemia major patients from Antalya, Turkey. Int J Endocrinol 2012;2012:573298.Suche in Google Scholar

13. Tantawy AA, El-Bostany EA, Matter RM, El-Ghoroury EA, Ragab S. Predictors of bone disease in Egyptian prepubertal children with β-thalassaemia major. Arch Med Sci 2010;6:584–91.Suche in Google Scholar

14. Vogiatzi MG, Autio KA, Schneider R, Giardina PJ. Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab 2004;17:1415–21.Suche in Google Scholar

15. Yazigi A, Maalouf G, Inati-Khoriati A, Tamim H, Saab C. Bone mineral density in beta-thalassemic Lebanese children. J Muskuloskelet Neuronal Interact 2002;2:463–8.Suche in Google Scholar

16. Carmina E, Di Fede G, Napoli N, Renda G, Vitale G, et al. Hypogonadism and hormone replacement therapy on bone mass of adult women with thalassemia major. Calcif Tissue Int 2004;74:68–71.Suche in Google Scholar

17. Anapliotou ML, Kastanias IT, Psara P, Evangelou EA, Liparaki M, et al. The contribution of hypogonadism to the development of osteoporosis in thalassemia major: new therapeutic approaches. Clin Endocrinol (Oxf) 1995;42: 279–87.Suche in Google Scholar

18. Molyvda-Athanasopoulou E, Sioundas A, Karatzas N, Aggellaki M, Pazaitou K, et al. Bone mineral density of patients with thalassemia major: four-year follow-up. Calcif Tissue Int 1999;64:481–4.Suche in Google Scholar

19. Lasco A, Morabito N, Gaudio A, Buemi M, Wasniewska M, et al. Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major. Osteoporos Int 2001;12:570–5.Suche in Google Scholar

Received: 2013-3-17
Accepted: 2013-9-16
Published Online: 2013-10-16
Published in Print: 2014-03-01

©2014 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Images in pediatric endocrinology
  4. Leprechaunism (Donohue syndrome): report of a case in a newborn
  5. Original articles
  6. Children and adolescents with type 1 diabetes in Germany are more overweight than healthy controls: results comparing DPV database and CrescNet database
  7. Age of onset of pubertal maturation of Thai boys
  8. Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children
  9. Early differentiation between good and poor response to growth hormone therapy in short children born small for gestational age (SGA) to improve the outcome of poor responders
  10. Children and adolescents with type 1 diabetes mellitus have a sixfold greater risk for prolonged QTc interval
  11. Effect of micronutrient supplementation on height velocity of underprivileged girls in comparison with un-supplemented healthy controls
  12. Insulin resistance in young adults born small for gestational age (SGA)
  13. The effect of childhood obesity on cardiac functions
  14. Adiponectin serum concentrations in newborn at delivery appear to be of fetal origin
  15. Thalassaemic Osteopathy: a cross-sectional preliminary study from Sri Lanka
  16. Health-related quality of life in Turner syndrome and the influence of key features
  17. Clinical analysis on 33 patients with hypothalamic syndrome in Chinese children
  18. The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation
  19. Molecular characterization of Chilean patients with a clinical diagnosis of Noonan syndrome
  20. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential
  21. The absence of mutations in homeobox candidate genes HOXA3, HOXB3, HOXD3 and PITX2 in familial and sporadic thyroid hemiagenesis
  22. A truncating DUOX2 mutation (R434X) causes severe congenital hypothyroidism
  23. Heterozygous GHR gene mutation in a child with idiopathic short stature
  24. A novel compound mutation of CYP27B1 in a Chinese family with vitamin D-dependent rickets type 1A
  25. A de novo mutation of DAX1 in a boy with congenital adrenal hypoplasia without hypogonadotropic hypogonadism
  26. Patient reports
  27. Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature
  28. Preterm ovarian hyperstimulation syndrome presented with vaginal bleeding: a case report
  29. Pituitary stalk lesion in a 13-year-old female
  30. Radiologic manifestation of a BCS1L-mutated patient
  31. Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene
  32. NKX2-1 mutations in brain-lung-thyroid syndrome: a case series of four patients
  33. A teenage boy with hypocalcemia after radioablation for Graves’ disease
  34. Short communication
  35. A common thyroid peroxidase gene mutation (G319R) in Turkish patients with congenital hypothyroidism could be due to a founder effect
  36. Letter to the Editor
  37. Endometriosis and migraine: what is there behind the scenes?
  38. 10.1515/jpem-2014-0999
Heruntergeladen am 20.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0104/html
Button zum nach oben scrollen